BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29490924)

  • 1. Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism.
    Kearon C; Parpia S; Spencer FA; Baglin T; Stevens SM; Bauer KA; Lentz SR; Kessler CM; Douketis JD; Moll S; Kaatz S; Schulman S; Connors JM; Ginsberg JS; Spadafora L; Bhagirath V; Liaw PC; Weitz JI; Julian JA
    Blood; 2018 May; 131(19):2151-2160. PubMed ID: 29490924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to d-dimer results; A cohort study.
    Kearon C; Parpia S; Spencer FA; Schulman S; Stevens SM; Shah V; Bauer KA; Douketis JD; Lentz SR; Kessler CM; Connors JM; Ginsberg JS; Spadafora L; Julian JA
    J Thromb Haemost; 2019 Jul; 17(7):1144-1152. PubMed ID: 31033194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study.
    Kearon C; Spencer FA; O'Keeffe D; Parpia S; Schulman S; Baglin T; Stevens SM; Kaatz S; Bauer KA; Douketis JD; Lentz SR; Kessler CM; Moll S; Connors JM; Ginsberg JS; Spadafora L; Julian JA;
    Ann Intern Med; 2015 Jan; 162(1):27-34. PubMed ID: 25560712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
    Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
    Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-dimer at venous thrombosis diagnosis is associated with risk of recurrence.
    Bjøri E; Johnsen HS; Hansen JB; Braekkan SK
    J Thromb Haemost; 2017 May; 15(5):917-924. PubMed ID: 28166605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism.
    Verhovsek M; Douketis JD; Yi Q; Shrivastava S; Tait RC; Baglin T; Poli D; Lim W
    Ann Intern Med; 2008 Oct; 149(7):481-90, W94. PubMed ID: 18838728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural antibodies to oxidation-specific epitopes: innate immune response and venous thromboembolic disease.
    Eichinger S; Kyrle PA; Kammer M; Eischer L; Ozsvar Kozma M; Binder CJ
    J Thromb Haemost; 2018 Jan; 16(1):31-35. PubMed ID: 29045005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH).
    Tosetto A; Iorio A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Douketis J
    J Thromb Haemost; 2012 Jun; 10(6):1019-25. PubMed ID: 22489957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residual vein thrombosis and serial D-dimer for the long-term management of patients with deep venous thrombosis.
    Prandoni P; Vedovetto V; Ciammaichella M; Bucherini E; Corradini S; Enea I; Cosmi B; Mumoli N; Visonà A; Barillari G; Bova C; Quintavalla R; Zanatta N; Pedrini S; Villalta S; Camporese G; Testa S; Parisi R; Becattini C; Cuppini S; Pengo V; Palareti G;
    Thromb Res; 2017 Jun; 154():35-41. PubMed ID: 28407492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-dimer levels over time and the risk of recurrent venous thromboembolism: an update of the Vienna prediction model.
    Eichinger S; Heinze G; Kyrle PA
    J Am Heart Assoc; 2014 Jan; 3(1):e000467. PubMed ID: 24385451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of D-Dimer Testing in Predicting Recurrence in Elderly Patients with Unprovoked Venous Thromboembolism.
    Tritschler T; Limacher A; Méan M; Rodondi N; Aujesky D
    Am J Med; 2017 Oct; 130(10):1221-1224. PubMed ID: 28522384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-dimer levels and recurrence in patients with unprovoked VTE and a negative qualitative D-dimer test after treatment.
    Kearon C; Parpia S; Spencer FA; Baglin T; Stevens SM; Bauer KA; Lentz SR; Kessler CM; Douketis JD; Moll S; Kaatz S; Schulman S; Connors JM; Ginsberg JS; Spadafora L; Liaw PC; Weitz JI; Julian JA
    Thromb Res; 2016 Oct; 146():119-125. PubMed ID: 27354153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study.
    Cosmi B; Legnani C; Tosetto A; Pengo V; Ghirarduzzi A; Testa S; Prisco D; Poli D; Tripodi A; Marongiu F; Palareti G;
    Blood; 2010 Jan; 115(3):481-8. PubMed ID: 19965693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.
    Palareti G; Legnani C; Cosmi B; Valdré L; Lunghi B; Bernardi F; Coccheri S
    Circulation; 2003 Jul; 108(3):313-8. PubMed ID: 12847064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial D-dimers after anticoagulant cessation in unprovoked venous thromboembolism: Data from the REVERSE cohort study.
    Xu Y; Khan F; Kovacs MJ; Sabri E; Carrier M; Righini M; Kahn SR; Wells PS; Anderson DR; Chagnon I; Crowther MA; White RH; Rodger M; Le Gal G
    Thromb Res; 2023 Nov; 231():32-38. PubMed ID: 37801772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "HERDOO2" clinical decision rule to guide duration of anticoagulation in women with unprovoked venous thromboembolism. Can I use any d-Dimer?
    Rodger MA; Le Gal G; Langlois NJ; Gin B; Mallick R; Giulivi A; Freedman M; Kovacs MJ;
    Thromb Res; 2018 Sep; 169():82-86. PubMed ID: 30031290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent thrombosis in patients with antiphospholipid antibodies and an initial venous or arterial thromboembolic event: A systematic review and meta-analysis.
    Ortel TL; Meleth S; Catellier D; Crowther M; Erkan D; Fortin PR; Garcia D; Haywood N; Kosinski AS; Levine SR; Phillips MJ; Whitehead N
    J Thromb Haemost; 2020 Sep; 18(9):2274-2286. PubMed ID: 32484606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the risk of recurrent venous thromboembolism. The Austrian study on recurrent venous thromboembolism (AUREC).
    Kyrle PA; Eischer L
    Hamostaseologie; 2013 Aug; 33(3):201-9. PubMed ID: 23712242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study.
    Palareti G; Cosmi B; Legnani C; Antonucci E; De Micheli V; Ghirarduzzi A; Poli D; Testa S; Tosetto A; Pengo V; Prandoni P;
    Blood; 2014 Jul; 124(2):196-203. PubMed ID: 24879813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antiphospholipid antibodies as risk factor for venous thromboembolism].
    Windyga J
    Pol Arch Med Wewn; 2002 Nov; 108(5):1065-70. PubMed ID: 12685247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.